Taro Pharmaceutical Industries Ltd. (TARO) Stake Lowered by Los Angeles Capital Management & Equity Research Inc.

Los Angeles Capital Management & Equity Research Inc. decreased its position in Taro Pharmaceutical Industries Ltd. (NYSE:TARO) by 7.8% during the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 51,420 shares of the company’s stock after selling 4,379 shares during the quarter. Los Angeles Capital Management & Equity Research Inc. owned approximately 0.13% of Taro Pharmaceutical Industries worth $5,762,000 as of its most recent SEC filing.

Several other large investors have also recently added to or reduced their stakes in the company. River Road Asset Management LLC raised its position in shares of Taro Pharmaceutical Industries by 33.3% in the second quarter. River Road Asset Management LLC now owns 65,470 shares of the company’s stock valued at $7,337,000 after purchasing an additional 16,350 shares during the period. Highstreet Asset Management Inc. bought a new position in shares of Taro Pharmaceutical Industries in the second quarter valued at approximately $244,000. Legal & General Group Plc raised its position in shares of Taro Pharmaceutical Industries by 4.7% in the second quarter. Legal & General Group Plc now owns 8,318 shares of the company’s stock valued at $932,000 after purchasing an additional 370 shares during the period. Alps Advisors Inc. raised its position in shares of Taro Pharmaceutical Industries by 4.9% in the second quarter. Alps Advisors Inc. now owns 37,037 shares of the company’s stock valued at $4,150,000 after purchasing an additional 1,737 shares during the period. Finally, LMR Partners LLP bought a new position in shares of Taro Pharmaceutical Industries in the second quarter valued at approximately $469,000. 14.24% of the stock is currently owned by institutional investors.

A number of equities analysts have recently commented on the stock. TheStreet raised shares of Taro Pharmaceutical Industries from a “c” rating to a “b-” rating in a research report on Thursday, July 20th. BidaskClub lowered shares of Taro Pharmaceutical Industries from a “hold” rating to a “sell” rating in a research report on Friday, August 11th. Finally, Credit Suisse Group downgraded shares of Taro Pharmaceutical Industries from an “outperform” rating to a “neutral” rating in a research note on Tuesday, May 23rd.

Shares of Taro Pharmaceutical Industries Ltd. (NYSE TARO) opened at 105.47 on Tuesday. The firm has a market cap of $4.27 billion, a P/E ratio of 10.74 and a beta of 0.65. Taro Pharmaceutical Industries Ltd. has a 52 week low of $92.28 and a 52 week high of $125.87. The stock has a 50 day moving average of $106.61 and a 200 day moving average of $112.14.

WARNING: This piece was first reported by Ticker Report and is owned by of Ticker Report. If you are reading this piece on another domain, it was illegally copied and reposted in violation of United States and international copyright and trademark legislation. The correct version of this piece can be accessed at https://www.tickerreport.com/banking-finance/2886309/taro-pharmaceutical-industries-ltd-taro-stake-lowered-by-los-angeles-capital-management-equity-research-inc.html.

About Taro Pharmaceutical Industries

Taro Pharmaceutical Industries Ltd. (Taro) is a science-based pharmaceutical company. The Company operates principally through three entities: Taro Pharmaceutical Industries Ltd. (Taro Israel), and two of its subsidiaries, Taro Pharmaceuticals Inc (Taro Canada) and Taro U.SA The Company markets over 200 pharmaceutical products in over 25 countries.

Institutional Ownership by Quarter for Taro Pharmaceutical Industries (NYSE:TARO)

Receive News & Ratings for Taro Pharmaceutical Industries Ltd. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Taro Pharmaceutical Industries Ltd. and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

How to Trade on Forex – 8 Steps for Beginners
How to Trade on Forex – 8 Steps for Beginners
Super Nintendo World Theme Park Officially Starts Construction
Super Nintendo World Theme Park Officially Starts Construction
Amazon and Apple Join Foxconn to Secure Chip Business of Toshiba
Amazon and Apple Join Foxconn to Secure Chip Business of Toshiba
Camera Zooms In and Can Recognize Faces
Camera Zooms In and Can Recognize Faces
Netflix Could See 150 Million Worldwide Subscribers
Netflix Could See 150 Million Worldwide Subscribers
LeEco Cutting Over 70% of Staff in U.S. Amidst Pull Back
LeEco Cutting Over 70% of Staff in U.S. Amidst Pull Back


Leave a Reply

© 2006-2017 Ticker Report. Google+.